Table 4 Factors associated with appropriateness of ceftriaxone utilization in the medicine wards of general hospitals in AA; February 2014 (n = 477)
Crude | Adjusted | ||||||
|---|---|---|---|---|---|---|---|
Factors | N | % | OR | 95 % CI | OR | 95 % CI | |
Public hospital | Age | ||||||
14–65 Yrs. | 329 | 87.5 | 1.34 | 0.72–2.49 | 0.80 | 0.40–1.50 | |
>65 Yrs. | 47 | 12.5 | 1.00 | 1.00 | 1.00 | 1.00 | |
Sex | |||||||
Male | 172 | 45.7 | 0.91 | 0.61–1.37 | 0.95 | 0.60–1.5 | |
Female | 204 | 54.3 | 1.00 | 1.00 | 1.00 | 1.00 | |
Days of hospital stays | |||||||
0–7 days | 110 | 29.25 | 1.00 | 1.00 | 1.00 | 1.00 | |
8–14 days | 133 | 35.40 | 5.90 | 3.30–10.50 | 6.00 | 3.40–10.80 | |
>14 days | 133 | 35.40 | 5.710 | 3.20–10.15 | 5.58 | 3.10–10.00 | |
Co morbidity | |||||||
0 | 60 | 16.0 | 1.00 | 1.00 | 1.00 | 1.00 | |
> = 1 | 316 | 84.0 | 1.68 | 0.95-2.95 | 1.60 | 0.89–3.00 | |
Co-prescribed | |||||||
0 | 6 | 1.6 | 1.00 | 1.00 | 1.00 | 1.00 | |
> = 1 | 370 | 98.4 | 0.95 | 0.19–4.807 | 1.10 | 0.20–6.00 | |
Private hospital | Age | ||||||
14–65 Yrs. | 73 | 72.3 | 0.64 | 0.34–1.94 | 1.60 | 0.60–4.00 | |
>65 Yrs. | 28 | 27.7 | 1.00 | 1.00 | 1.00 | 1.00 | |
Sex | |||||||
Male | 68 | 67.3 | 1.40 | 0.59–3.34 | 1.20 | 0.50–3.10 | |
Female | 33 | 32.7 | 1.00 | 1.00 | 1.00 | 1.00 | |
Days of hospital stay | |||||||
0–7 days | 76 | 75.2 | 1.00 | 1.00 | 1.00 | 1.00 | |
8–14 days | 17 | 16.8 | 3.00 | 1.00–9.11 | 3.00 | 1.00–9.12 | |
>14 days | 8 | 8.0 | 3.61 | 0.80–16.37 | 3.50 | 0.75–16.58 | |
Comorbidity | |||||||
0 | 37 | 36.6 | 1.00 | 1.00 | 1.00 | 1.00 | |
> = 1 | 64 | 63.4 | 1.50 | 0.65–3.55 | 1.23 | 0.48–3.20 | |
Co-prescribed | |||||||
0 | 2 | 2.0 | 1.00. | 1.00 | 1.00 | 1.00 | |
>1 | 99 | 98.0 | 0.63 | 0.03–10.30 | 0.38 | 0.02–6.73 | |